Articles published by ANGLE plc
Angle PLC Announces Issue of Equity
July 08, 2022
Angle PLC Announces Issue of Equity
June 23, 2022
ANGLE receives FDA clearance for Parsortix
May 25, 2022
Angle PLC Announces Preliminary Results
April 28, 2022
Angle PLC Announces Update on Laboratory Accreditation
March 15, 2022
Angle PLC Announces Holding(s) in Company
March 02, 2022
Angle PLC Announces Issue of Equity
February 18, 2022
Angle PLC Announces Potential in Immunotherapy Treatment Selection
January 21, 2022
Angle PLC Announces Concordance of Parsortix with tissue biopsy
January 17, 2022
Angle PLC Announces Update on Lab Accreditation and Ovarian Study
January 13, 2022
Angle PLC Announces Insight into Drug Resistance in NSCLC
January 10, 2022
Angle PLC Announces Issue of Equity
December 22, 2021
Angle PLC Announces Issue of Equity
December 01, 2021
Angle PLC Announces Parsortix in RNA analysis of CTCs as tool in NSCLC
December 01, 2021
Angle PLC Announces Issue of Equity
November 26, 2021
Angle PLC Announces Issue of Equity
November 17, 2021
Angle PLC Announces Issue of LTIP Options and Share Options
November 15, 2021